2019
DOI: 10.1016/j.bjae.2019.05.006
|View full text |Cite
|
Sign up to set email alerts
|

Postoperative vomiting in children

Abstract: Identify children at risk of postoperative vomiting (POV).Apply a risk stratification strategy to distinguish 'high-risk' children. Communicate risk and treatment strategies appropriately. Provide effective prophylaxis and treatment of POV in children.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(7 citation statements)
references
References 23 publications
0
3
0
Order By: Relevance
“…Other drugs such as neurokinin 1 (NK1) receptor antagonists (e.g., aprepitant and fosaprepitant) have been successfully tried in post-chemotherapy vomiting with favorable results. Data support their safety in the pediatric population (14), and there is evidence of similar effects to those of ondansetron in the prevention of POV in adults (15). On the other hand, non-pharmacological treatments like P6 stimulation with different acupuncture techniques have shown to reduce POV substantially, with effects similar to those of some antiemetics like ondansetron, droperidol and metoclopramide (11).…”
Section: ¿Qué Aporta Este Estudio De Nuevo?mentioning
confidence: 98%
“…Other drugs such as neurokinin 1 (NK1) receptor antagonists (e.g., aprepitant and fosaprepitant) have been successfully tried in post-chemotherapy vomiting with favorable results. Data support their safety in the pediatric population (14), and there is evidence of similar effects to those of ondansetron in the prevention of POV in adults (15). On the other hand, non-pharmacological treatments like P6 stimulation with different acupuncture techniques have shown to reduce POV substantially, with effects similar to those of some antiemetics like ondansetron, droperidol and metoclopramide (11).…”
Section: ¿Qué Aporta Este Estudio De Nuevo?mentioning
confidence: 98%
“…Especially children at least 3 years of age are at risk of PONV. Thus, knowledge of available (pharmacologic) countermeasures is key for adequate care in this vulnerable patient group [21]. As in adults, use of combination therapy is recommended for children with one or more risk factors, and thus virtually for all children.…”
Section: Drugs For Postoperative Nausea and Vomiting Prophylaxis In C...mentioning
confidence: 99%
“…Predictors for KAV include increasing age (peak incidence at 12 years), IM route of administration and unusually high intravenous (IV) dose (initial dose of ≥2.5 mg/kg or a total dose of ≥5.0 mg/kg) 12 . KAV can be distressing for both the patient and family, 18 potentially decreasing overall satisfaction with care. Reduction in the incidence of KAV could improve patient experience 19 and satisfaction.…”
Section: Introductionmentioning
confidence: 99%